Visiting Fellows

Visiting Fellows participate in working groups and activities that support research on a number of initiatives in health care delivery and payment reform, biomedical innovation for pharmaceuticals and devices, and health policy education and workforce development. The appointment as a Visiting Fellow is reserved for individuals who, through their collaboration with the Duke-Margolis Center, are deserving of an affiliation but do not have any formal academic responsibilities nor do they receive financial support from the university.


Patrick Conway, MD, MSc

Dr. Conway earned his BS at Texas A&M University, his MD at Baylor College of Medicine and his MSc at the University of Pennsylvania.  He is a member of the American Board of Pediatrics, the American Academy of Pediatrics, the National Academy of Medicine, and the Society of Hospital Medicine. Prior to joining BCBSNC, he served as Chief Medical Officer, Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation (CMMI) and as Director of Hospital Medicine at the Cincinnati Children’s Hospital Medical Center. He has also served as Chief Medical Officer at the U.S. Department of Health and Human Services and as a White House Fellow at DHHS.

Regina Labelle, JD
Regina LaBelle, JD, Principal, LaBelle Strategies

Regina LaBelle, JD, is a principal with LaBelle Strategies, advising governments and non-profit organizations on effective strategies to address today's opioid epidemic. A frequent commentator on the opioid issue, Regina has appeared on MSNBC and is a regular contributor to The Hill. Until January 2017, Regina was Chief of Staff in the White House Office of National Drug Control Policy (ONDCP) where she served for eight years as a political appointee.  While at ONDCP, she co-authored and helped to implement the Administration's plan to address the opioid epidemic. Regina represented ONDCP before Congress, at national conferences, and with the media.  Skilled at public speaking, writing, and strategy development, Regina's previous work as legal counsel to the Mayor of Seattle, as well as in the Federal Government, provide a unique perspective on today's public policy challenges. A graduate of Georgetown University Law Center in Washington, DC and magna cum laude graduate of Boston College, Regina lives with her husband and son in Maryland.

Mohit Kaushal, MD, MBA
Mohit Kaushal, MD, MBA, Special Advisor at General Atlantic

Dr. Kaushal’s extensive career in investing, clinical medicine, academia, and public policy includes his work as a lead investor, board member, or advisor to transformational healthcare companies.  He was a member of the White House Health IT task force, a cross-agency team implementing the technology aspects of Health Reform. He also built and led the first dedicated healthcare team at the Federal Communications Commission. Dr. Kaushal is also an adjunct professor at Stanford University Medical School with a joint appointment in the Biomedical Data Science Department and the Clinical Excellence Research Center. He was previously a Visiting Scholar at the Brookings Institution and serves on the FDASIA Workgroup of the Health IT Policy Committee and to the National Committee on Vital and Health Statistics, advising HHS on Data Access and Use. An Emergency Medicine Physician, Dr. Kaushal earned his MD with distinction from Imperial College of Science, Technology and Medicine, London and his MBA at Stanford University.

David Muhlestin, PhD, JD
David Muhlestein, PhD, JD, Chief Research Officer, Leavitt Partners

David Muhlestein, PhD, JD, is Chief Research Officer at Leavitt Partners. He directs the study of accountable care organizations through the LP Center for Accountable Care Intelligence and leads the firm’s quantitative evaluation of health care markets. He is an expert in using policy analysis, predictive modeling, and applied analytics to understand the evolving health care landscape.

David also serves as Adjunct Assistant Professor of The Dartmouth Institute (TDI) at the Geisel School of Medicine at Dartmouth College and is a visiting fellow at the Accountable Care Learning Collaborative.  In both of these roles he conducts research to translate learnings of high-performing organizations for the benefit of the broader health care system.

David earned his doctorate in health services management and policy, JD, MHA, and MS from The Ohio State University, and a BA from Brigham Young University.

Edmund Pezalla, MD, MPH
Edmund Pezalla, MD, MPH, Vice President and National Medical Director for Pharmaceutical Policy and Strategy at Aetna

Dr. Pezalla is a recognized leader in the development of advanced coverage and payment systems for pharmaceuticals. Dr. Pezalla is Aetna’s lead executive for public policy related to pharmaceuticals and is also responsible for public policy coordination and quality of care in the Office of the Chief Medical Officer, Aetna. Dr. Pezalla has consulted on projects related to technology development and coverage decisions for the President’s Council of Advisors on Science and Technology, the American Academy of Pediatrics, the Institute for Clinical and Economic Review and the Brookings Institution. He is a member of the Board of Directors of the Pharmacy Quality Alliance and the Connecticut Biosciences Innovation Fund. Dr. Pezalla received his bachelor’s degree in Biophysics and his degree in Medicine from Georgetown University, and Masters in Public Health from the University of California at Berkeley. He was as health services research fellow and PhD student at the University of Michigan in Ann Arbor where he completed all but the dissertation in the program in Health Services Organization and Policy.

Michael Pignone, MD, MPH
Michael Pignone, MD, MPH, Chair of Internal Medicine at the University of Texas Dell Medical School

Dr. Pignone is the inaugural chair of the department of internal medicine and a professor of medicine at the Dell Medical School. He was previously Professor of Medicine, chief of the Division of General Internal Medicine, and director of the Institute for Healthcare Quality Improvement at the University of North Carolina at Chapel Hill. His research is focused on chronic disease screening, prevention, and treatment, and on improving medical decision making, particularly in heart disease prevention, colorectal cancer screening, and management of common chronic conditions such as diabetes and heart failure. He has developed and tested interventions to mitigate literacy-related health disparities and to improve the use of appropriate preventive services. He serves on the U.S. Preventive Services Task Force and has served on a number of national guideline and quality improvement panels. He has served as an Associate Editor for Medical Decision Making, a Medical Editor for the Informed Medical Decisions Foundation, and as an Editorial Board member for JAMA Internal Medicine. He earned his MD and completed residency training in primary care internal medicine at the University of California-San Francisco. He then completed fellowship training through the Robert Wood Johnson Clinical Scholars Program, earning a master’s degree in epidemiology from the UNC School of Public Health.

Marc Samuels, MD, JD, Founder and CEO of ADVI

As CEO of ADVI, Marc Samuels leads all of the firm’s strategy, team and operations, across the firm’s three locations, its global network and advisor ecosystem. Marc's perch atop one of Washington, DC's busiest  healthcare consulting firms across the policy, strategy and data analytics landscapes, provides Duke Margolis a unique perspective and learned insight into many of our ongoing workstreams in value and transformation, payment policy, and regulatory alignment of HHS, CMS, FDA and OMB. As one of our Fellows during the advent of the COVID 19 national emergency, Marc's work with Duke Margolis will specifically center around payment for new vaccines and biologics including reducing regulatory barriers and providing best access. 

Prior to founding ADVI and its predecessor company HillCo HEALTH, Marc served both President George HW Bush and President George W Bush, in federal and state government respectively.  Marc began his consulting career with his first partner, J. Michael Hudson, a former HCFA Deputy Administrator under President Bush and former OMB official under President Reagan. Marc speaks frequently on business strategy and policy matters, including an annual panel curated by ADVI at the Biopharma Congress . His comments and analyses have appeared in STAT News, The Pink Sheet, Fierce Healthcare, In Vivo, Journal of Oncology Practice, Medical Economics, the Fort Worth Star-Telegram, the Dallas Morning News, and Texas Medicine. He is policy counsel to NCCN and on the NCCN Foundation Board. Marc also participates as founding board member of the University of California San Francisco Roseman Institute's BUILD Program. Marc attended Yale School of Medicine’s MPH Program, the University of Texas School of Law, and the University of Michigan where he focused on neuroscience.

Rachel Sherman, MD, MPH, Former Principal Deputy Commissioner FDA, Founder at Rachel Sherman Partners

Dr. Sherman, recently the US FDA principal deputy commissioner, is now working with several groups to provide her expertise in regulatory science and real-world evidence development and help improve clinical trial efficiency.. She will be working in regulatory science and evidence development, and helping the center expand its activities in these areas. Rachel will focus on regulatory science and real world evidence development topics, including the links between payment policies and evidence development, as well as developing new programs for the center, such as in the area of global regulatory best practices and more efficient and effective clinical trials. Dr. Sherman is an internist with a subspecialty in infectious diseases.  She received her MPH from Johns Hopkins University, her MD from Mount Sinai School of Medicine, and her BA in Mathematics from Washington University in St. Louis.  She has served over the years as attending physician in the Division of Infectious Diseases, Veterans Affairs Medical Center; Clinical Assistant Professor of Medicine (infectious diseases) at Georgetown University; and volunteer physician with Montgomery Mobile Health.